Pandit-Taskar, N., O’Donoghue, J. A., Morris, M. J., Wills, E. A., Schwartz, L. H., Gonen, M., . . . Divgi, C. R. (2008). Antibody mass escalation study in patients with castration resistant prostate cancer using (111)I-J591: Lesion detectability and dosimetric projections for (90)Y radioimmunotherapy.

Pandit-Taskar, Neeta, Joseph A. O’Donoghue, Michael J. Morris, Eze A. Wills, Lawrence H. Schwartz, Mithat Gonen, Howard I. Scher, Steven M. Larson, and Chaitanya R. Divgi. Antibody Mass Escalation Study in Patients With Castration Resistant Prostate Cancer Using (111)I-J591: Lesion Detectability and Dosimetric Projections for (90)Y Radioimmunotherapy. 2008.

Pandit-Taskar, Neeta, et al. Antibody Mass Escalation Study in Patients With Castration Resistant Prostate Cancer Using (111)I-J591: Lesion Detectability and Dosimetric Projections for (90)Y Radioimmunotherapy. 2008.